Hereditary Neuropathy Foundation BlogStay up to date with our most recent news and updates on CMT and INs.
Love, Sex & Disability Revealed in Groundbreaking New Documentary by Ben Duffyread more
StarWise Therapeutics & HNF Form A Strategic Alliance to Bring a NextGen HDAC6 Drug Therapy to CMT2A (MFN2) Patients
HNF has been committed to funding HDAC inhibitor research since 2014.read more
HNF takes action and joins genomics revolution for CMT and rare forms of IN.read more
The HNF 2018 Patient-Centered Behavioral Health Summit was one-of-kind: HNF launched a new curriculum.read more
Exciting news for the CMT patient community with the first potential treatment ever!read more
HNF and Acceleron Pharma have been collaborating since January, 2016. Acceleron Pharma is a ”clinical stage biopharmaceutical company.”read more